Profile picture

Doctor John Molvin

Department of Cardiology, Malmoe (Sweden)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Nutritional risk in hospitalized heart failure patients - a proteomic approach to pathway enrichment analysis
Presentation
Nutritional risk in hospitalized heart failure patients - a proteomic approach to pathway enrichment analysis
Selenium supplementation in heart failure: design and rationale of the SIRI-HF Trial
Presentation
Selenium supplementation in heart failure: design and rationale of the SIRI-HF Trial
Pathways and biomarkers of selenium deficiency in heart failure patients
Presentation
Pathways and biomarkers of selenium deficiency in heart failure patients
Selenium, selenoprotein P and autoantibodies to selenium transport proteins in Swedish heart failure patients - a pilot study in preparation for a randomized supplementation trial
Presentation
Selenium, selenoprotein P and autoantibodies to selenium transport proteins in Swedish heart failure patients - a pilot study in preparation for a randomized supplementation trial
Selenium deficiency is associated with anemia in heart failure patients - The HARVEST Study
Presentation
Selenium deficiency is associated with anemia in heart failure patients - The HARVEST Study
Selenoprotein-P deficiency is associated with higher risk of incident heart failure
Presentation
Selenoprotein-P deficiency is associated with higher risk of incident heart failure
Differences in clinical profile, treatment and outcomes between heart failure patients treated in cardiology wards and internal medicine wards
Presentation
Differences in clinical profile, treatment and outcomes between heart failure patients treated in cardiology wards and internal medicine wards
The antimicrobial protein Azurocidin-1 is associated with prevalent diastolic dysfunction and incident congestive heart failure in a Swedish population cohort
Presentation
The antimicrobial protein Azurocidin-1 is associated with prevalent diastolic dysfunction and incident congestive heart failure in a Swedish population cohort
The clinical use of bioactive adrenomedullin and proenkephalin A in detecting congestion, renal dysfunction and clinical outcomes in two independent acute heart failure cohorts
Presentation
The clinical use of bioactive adrenomedullin and proenkephalin A in detecting congestion, renal dysfunction and clinical outcomes in two independent acute heart failure cohorts
Galectin 4 bridging the gap in cardiometabolic disease predicting diabetes, coronary events and mortality in a Swedish population cohort
Presentation
Galectin 4 bridging the gap in cardiometabolic disease predicting diabetes, coronary events and mortality in a Swedish population cohort

ESC 365 is supported by